P. Martin Paslick - 12 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP and CIO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
12 Apr 2023
Transactions value $
-$1,214,303
Form type
4
Filing time
14 Apr 2023, 17:51:12 UTC
Previous filing
12 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $520K +6.34K +25.73% $81.96 31K 12 Apr 2023 Direct F1
transaction HCA Common Stock Tax liability -$995K -3.65K -11.79% $272.38 27.3K 12 Apr 2023 Direct F1
transaction HCA Common Stock Sale -$739K -2.69K -9.83% $275.00 24.6K 14 Apr 2023 Direct F1
holding HCA Common Stock 3K 12 Apr 2023 by 2021 Trust
holding HCA Common Stock 60K 12 Apr 2023 By PMP 2020 Trust
holding HCA Common Stock 64K 12 Apr 2023 by RJP 2020 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -6.34K -100% $0.00* 0 12 Apr 2023 Common Stock 6.34K $81.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.